Paragon Care Limited (ASX:PGC)

Market Cap	355.89M
Revenue (ttm)	3.61B
Net Income (ttm)	20.57M
Shares Out	1.66B
EPS (ttm)	0.01
PE Ratio	17.34
Forward PE	10.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,821,261
Average Volume	1,614,460
Open	0.2150
Previous Close	0.2150
Day's Range	0.2050 - 0.2200
52-Week Range	0.2000 - 0.5900
Beta	1.42
RSI	33.26
Earnings Date	Feb 26, 2026

About Paragon Care

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, b...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2005
• Employees: 550
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PGC

Financial Performance

In 2025, Paragon Care's revenue was 3.61 billion, an increase of 21.68% compared to the previous year's 2.97 billion. Earnings were 20.57 million, an increase of 151.52%.